Overview

Efficacy of Tamsulosin Oral-controlled Absorption System (OCAS) in the Treatment of Distal Ureteral Stones

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
This is a randomized double blind placebo-controlled study that will assess the efficacy of Tamsulosin oral-controlled absorption system (OCAS) 0.4 mg in the conjunctive medical treatment of distal ureteral stones with a size of 4-10 mm compared to placebo in control group.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
ChaingMai University
Treatments:
Tamsulosin
Criteria
Inclusion Criteria:

- Male or female patient aged => 18 years.

- Patients who have distal ureteral stones with a size of 4-10 mm

- Written informed consent has been obtained.

Exclusion Criteria:

- Patients with history of ureteral surgery

- Patients with urinary tract infection

- Patient with diabetes and peptic ulcer

- Patient with renal dysfunction (elevated of serum creatinine level)

- Patients with severe hydronephrosis

- Patients with history of passing stones

- Pregnancy

- Patients who desire to withdraw from the study